Plasminogen activator and cancer
- PMID: 6376129
- DOI: 10.1016/0277-5379(84)90001-4
Plasminogen activator and cancer
Abstract
Plasminogen activator is a protease which catalyses the conversion of the inactive plasminogen to the active plasmin. Most transformed cell lines and solid tumors produce elevated levels of plasminogen activator compared with nontransformed counterparts. This increased synthesis of plasminogen activator may play a role in tumorigenesis, cancer invasion and metastasis. Measurement of plasminogen activator in tumor extracts and body fluids may provide diagnostic and prognostic information. Finally, since plasminogen activator is an estradiol-inducible enzyme, its measurement in breast carcinomas might be a marker for a functional estrogen receptor.
Similar articles
-
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.Int J Cancer. 1995 May 29;61(5):597-600. doi: 10.1002/ijc.2910610502. Int J Cancer. 1995. PMID: 7768629
-
[The clinical prospects for the study of the plasminogen activation system in breast cancer].Vestn Ross Akad Med Nauk. 1999;(8):58-61. Vestn Ross Akad Med Nauk. 1999. PMID: 10487126 Review. Russian.
-
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.Cancer. 1988 Aug 1;62(3):531-3. doi: 10.1002/1097-0142(19880801)62:3<531::aid-cncr2820620315>3.0.co;2-b. Cancer. 1988. PMID: 3134120
-
Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.Biomed Biochim Acta. 1991;50(4-6):731-41. Biomed Biochim Acta. 1991. PMID: 1801751
-
Plasminogen activators and cancer.Blood Coagul Fibrinolysis. 1990 Dec;1(6):681-7. Blood Coagul Fibrinolysis. 1990. PMID: 2133247 Review.
Cited by
-
Paracrine control of differentiation in the alveolar carcinoma, A549, by human foetal lung fibroblasts.Br J Cancer. 1991 Oct;64(4):693-9. doi: 10.1038/bjc.1991.383. Br J Cancer. 1991. PMID: 1654985 Free PMC article.
-
Identification of a plasminogen activator derived from nasopharyngeal carcinoma.Eur Arch Otorhinolaryngol. 1990;247(6):374-8. doi: 10.1007/BF00179011. Eur Arch Otorhinolaryngol. 1990. PMID: 2126177
-
Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).In Vitro Cell Dev Biol. 1988 Oct;24(10):965-71. doi: 10.1007/BF02620867. In Vitro Cell Dev Biol. 1988. PMID: 2903136
-
Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.World J Gastroenterol. 2005 Oct 7;11(37):5751-6. doi: 10.3748/wjg.v11.i37.5751. World J Gastroenterol. 2005. PMID: 16270380 Free PMC article.
-
Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.Br J Exp Pathol. 1988 Oct;69(5):685-95. Br J Exp Pathol. 1988. PMID: 3143395 Free PMC article.